MRC — Mercator Medical SA Income Statement
0.000.00%
Last trade - 00:00- PLN535.74m
- PLN414.78m
- PLN574.18m
Annual income statement for Mercator Medical SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,727 | 543 | 469 | 542 | 574 |
| Cost of Revenue | |||||
| Gross Profit | 622 | 26.4 | 11.3 | 68.8 | 102 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,264 | 724 | 556 | 511 | 581 |
| Operating Profit | 463 | -181 | -87.1 | 31.1 | -6.91 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 477 | -186 | -3.79 | 35.4 | 28.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 445 | -191 | -22.8 | 43.4 | 29.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 447 | -190 | -19.7 | 44.6 | 28.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 447 | -190 | -19.7 | 44.6 | 28.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 45.5 | -20 | -4.03 | 4.46 | 3.06 |
| Dividends per Share |